Search Results 781-790 of 18161 for monoclonal antibody

  1. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

    Regorafenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab or panitumumab, ...

  2. Study To Evaluate The Efficacy And Safety Of MEDI9929 (AMG 157) In Adult Subjects With Inadequately Controlled, Severe Asthma - Mayo Clinic

    ... monoclonal antibody specific for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled ...

  3. Medical Research & Education - Mayo Clinic News Network

    Susan Murphy. February 27, 2021. Monoclonal antibodies: Update on this COVID-19 experimental therapy featured image. COVID-19. Monoclonal antibodies: Update on ...

  4. A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14) - Mayo Clinic

    About this study. The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in ...

  5. Xinyan Wu, Ph.D. - Mayo Clinic Faculty Profiles

    Developing novel targeted therapies including humanized monoclonal antibody and antibody drug conjugate to target AXL receptor tyrosine kinase for triple ...

  6. Living With Cancer: Understanding prostate cancer, one man at a time - Mayo Clinic News Network

    Monoclonal antibody drugs for cancer: How they work. These drugs use your immune system to help fight cancer. Learn how the medications work, what to discuss ...

  7. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibodies: Update on this COVID-19 experimental therapy featured image. COVID-19. Monoclonal antibodies: Update on this COVID-19 experimental ...

  8. Kidney Transplant Clinical Trials - Mayo Clinic Research

    The purpose of this study is to investigate whether clazakizumab (an anti-interleukin (IL)-6 monoclonal antibody ... antibody specific for their deceased donor.

  9. A Clinical Trial To Evaluate Efficacy And Safety Of Xeomin® Injections For Preventing Chronic Migraine

    * Discontinuation of anti-calcitonin gene-related peptide (CGRP) / anti-CGRP receptor monoclonal antibody treatment less than 5 months prior to screening.

  10. T Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving dendritic cell therapy, cryosurgery and ...